Home
Ablynx

Ablynx Market Share Analysis for November 2025

Discover how Sanofi leverages AI and technology platforms in healthcare to drive innovation, accelerate drug discovery, and improve patient care.

Health > Biotechnology and Pharmaceuticals

Domainablynx.com

Year Founded2001

Employees201 - 500

Annual Revenue$100M - $200M

Ablynx

Ablynx (including company regionals)

ablynx.com

See more website traffic and engagement information

Ablynx Revenue up to November 2025 is 100M - 200M

revenue generated by Ablynx top domains

Ablynx top domains revenue over 3 years

Revenue for Ablynx top domains

ablynx.com100M - 200M

See more with Sales Intelligence

Total visits to Ablynx's top domains

Understand Ablynx market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Ablynx's top domains

Analyze Ablynx engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Ablynx's top domains

See how Ablynx keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Ablynx top competitors by domain

Top similar sites in November 2025, ranked by their affinity

tigenix.comCompany NameTiGenix N.V.Employees51 - 200HQBelgium, LeuvenAnnual revenue$50M - $75MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Ablynx

These are the website technologies, by industry, used by Ablynx top domains

Widget (3)

reCAPTCHA

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

Social (2)

Twitter

More Technologies

5

See all

News & Signals from Ablynx

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSanofi acquired Ablynx N.V for $9B on Jan 1st '18.The deal – which includes an upfront payment of $30 million and possible future payments that could drive the total value up to $400 million – will combine miRecule’s RNA expertise with Sanofi’s nanobody technology, bolted on when it acquired Ablynx in a €3.9 billion deal in 2018.

NewsAblynx N.V partners with Taisho Pharmaceutical Co., Ltd..(Ablynx, a Sanofi unit, has partnered with the Japanese firm Taisho Pharmaceutical Co. to develop the drug commercially.)

NewsLeonie leaves Ablynx N.V.Leonie joins the Company from Ablynx, a Sanofi Company, where she was responsible for the GMP QC of Cablivi and early stage nanobody projects.